Cousin S, Cantarel C, Guégan J-P, Gomez-Roca C, Metges J-P, Adenis A, Pernot S, Bellera C, Kind M, Auzanneau C, Soubeyran I, Bessede A, Italiano A Regorafenib-Avelumab combination in patients with microsatellite stable colorectal cancer (REGOMUNE) : a single arm, open-label, phase II trial. Clin Cancer Res. 2021-01-25. doi:10.1158/1078-0432.CCR-20-3416
Assenat E, Mineur L, Mollevi C, Lopez-Crapez E, Lombard-Bohas C, Samalin E, Portales F, Walter T, de Forges H, Dupuy M, Boissière-Michot F, Ho-Pun-Cheung A, Ychou M, Mazard T Phase II study evaluating the association of gemcitabine, trastuzumab and erlotinib as first-line treatment in patients with metastatic pancreatic adenocarcinoma (GATE 1). Int J Cancer. 2021;148(3):682-691. doi:10.1002/ijc.33225
Verkarre V, Bibeau F [The inherited cancers, the pathologist]. Ann Pathol. 2020;40(2):61-62. doi:10.1016/j.annpat.2020.02.016
Cohen R, Pudlarz T, Garcia-Larnicol M-L, Vernerey D, Dray X, Clavel L, Jary M, Piessen G, Zaanan A, Aparicio T, Louvet C, Tournigand C, Chibaudel B, Tougeron D, Guimbaud R, Benouna J, Adenis A, Sokol H, Borg C, Duval A, Svrcek M, André T [Localized MSI/dMMR gastric cancer patients, perioperative immunotherapy instead of chemotherapy: The GERCOR NEONIPIGA phase II study is opened to recruitment]. Bull Cancer. 2020;107(4):438-446. doi:10.1016/j.bulcan.2019.11.016
Adenis A, Samalin E, Mazard T, Portales F, Mourregot A, Ychou M [Does the FLOT regimen a new standard of perioperative chemotherapy for localized gastric cancer?]. Bull Cancer. Jan 21, 2020. doi:10.1016/j.bulcan.2019.12.005
Bronkhorst A, Ungerer V, Diehl F, Anker P, Dor Y, Fleischhacker M, Gahan P, Hui L, Holdenrieder S, Thierry A Towards systematic nomenclature for cell-free DNA. Hum Genet. Oct 29, 2020. doi:10.1007/s00439-020-02227-2
Samalin E, Adenis A TAS-118 plus oxaliplatin in advanced gastric cancer: is it worth it?. Lancet Oncol.. Jul 16, 2020. doi:10.1016/S1470-2045(20)30337-5
Khashper A, Addley H, Abourokbah N, Nougaret S, Sala E, Reinhold C T2-Hypointense Adnexal Lesions: An Imaging Algorithm. Radiographics. 2020;40(4):1200. doi:10.1148/rg.2020204005
Samalin E, Fouchardière C, Boige V, Senellart H, Guimbaud R, Galais M-P, Lièvre A, Seitz J-F, Metges J-P, Bouché O, Boissière-Michot F, Lopez-Crapez E, Bibeau F, Ho-Pun-Cheung A, Ychou M, Adenis A, Di Fiore F, Mazard T Sorafenib Plus Irinotecan Combination in Patients With RAS-mutated Metastatic Colorectal Cancer Refractory To Standard Combined Chemotherapies: A Multicenter, Randomized Phase 2 Trial (NEXIRI-2/PRODIGE 27). Clin Colorectal Cancer. May 15, 2020. doi:10.1016/j.clcc.2020.04.008
Jha P, P?der L, Bourgioti C, Bharwani N, Lewis S, Kamath A, Nougaret S, Soyer P, Weston M, Castillo R, Kido A, Forstner R, Masselli G Society of Abdominal Radiology (SAR) and European Society of Urogenital Radiology (ESUR) joint consensus statement for MR imaging of placenta accreta spectrum disorders. Eur Radiol. 2020;30(5):2604-2615. doi:10.1007/s00330-019-06617-7
Thierry A SARS-CoV2 may evade innate immune response, causing uncontrolled neutrophil extracellular traps formation and multi-organ failure. Clin. Sci.. 2020;134(12):1295-1300. doi:10.1042/CS20200531
Cohen R, Bennouna J, Meurisse A, Tournigand C, Tougeron D, Borg C, Mazard T, Chibaudel B, Garcia-Larnicol M-L, Svrcek M, Vernerey D, Menu Y, André T RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the GERCOR NIPICOL phase II study. J Immunother Cancer. 2020;8(2):e001499. doi:10.1136/jitc-2020-001499
Kojima T, Shah M, Muro K, Francois E, Adenis A, Hsu C-H, Doi T, Moriwaki T, Kim S-B, Lee S-H, Bennouna J, Kato K, Shen L, Enzinger P, Qin S-K, Ferreira P, Chen J, Girotto G, de la Fouchardiere C, Al-Rajabi R, Lordick F, Wang R, Suryawanshi S, Bhagia P, Kang S, Metges J-P Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer. J Clin Oncol. Oct 07, 2020. doi:10.1200/JCO.20.01888
Nougaret S, McCague C, Tibermacine H, Vargas H, Rizzo S, Sala E Radiomics and radiogenomics in ovarian cancer: a literature review. Abdom Radiol (NY). Nov 11, 2020. doi:10.1007/s00261-020-02820-z
Nougaret S, Monsonis B, Molinari N, Piron L, Kassam Z, Cassinotto C, Guiu B Quantification of liver fat content in liver and primary liver lesions using triple-echo-gradient-echo MRI. Eur Radiol. 2020-4-22. doi:10.1007/s00330-020-06757-1
Delattre J-F, Cohen R, Henriques J, Falcoz A, Emile J-F, Fratte S, Chibaudel B, Dauba J, Dupuis O, Bécouarn Y, Bibeau F, Taieb J, Louvet C, Vernerey D, André T, Svrcek M Prognostic Value of Tumor Deposits for Disease-Free Survival in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the IDEA France Phase III Trial (PRODIGE-GERCOR). JCO. 2020-03-13. doi:10.1200/JCO.19.01960
Thierry A Neutrophil Extracellular Traps and By-Products Play a Key Role in COVID-19: Pathogenesis, Risk Factors, and Therapy. J Clin Med. 2020;9(9). doi:10.3390/jcm9092942
Maciel C, Bharwani N, Kubik-Huch R, Manganaro L, Otero-Garcia M, Nougaret S, Alt C, Cunha T, Forstner R MRI of female genital tract congenital anomalies: European Society of Urogenital Radiology (ESUR) guidelines. Eur Radiol. 2020-3-27. doi:10.1007/s00330-020-06750-8
Veeraraghavan H, Friedman C, DeLair D, Nin?evi? J, Himoto Y, Bruni S, Cappello G, Petkovska I, Nougaret S, Nikolovski I, Zehir A, Abu-Rustum N, Aghajanian C, Zamarin D, Cadoo K, Diaz L, Leitao M, Makker V, Soslow R, Mueller J, Weigelt B, Lakhman Y Machine learning-based prediction of microsatellite instability and high tumor mutation burden from contrast-enhanced computed tomography in endometrial cancers. Sci Rep. 2020;10(1):17769. doi:10.1038/s41598-020-72475-9
Tanos R, Tosato G, Al Amir Dache Z, Pique Lasorsa L, Tousch G, El Messaoudi S, Meddeb R, Diab Assaf M, Ychou M, Pezet D, Gagnière J, Colombo P-E, Jacot W, Dupuy M, Adenis A, Mazard T, Mollevi C, Sayagués J, Colinge J, Thierry A Machine Learning-Assisted Evaluation of Circulating DNA Quantitative Analysis for Cancer Screening. Adv Sci (Weinh). 2020;7(18):2000486. doi:10.1002/advs.202000486
Bascoul-Mollevi C, Barbieri A, Bourgier C, Conroy T, Chauffert B, Hebbar M, Jacot W, Juzyna B, Gourgou S, Bonnetain F, Touraine C, Anota A Longitudinal analysis of health-related quality of life in cancer clinical trials: methods and interpretation of results. Qual Life Res. Aug 18, 2020. doi:10.1007/s11136-020-02605-3
Selvy M, Pereira B, Kerckhove N, Gonneau C, Feydel G, Pétorin C, Vimal-Baguet A, Melnikov S, Kullab S, Hebbar M, Bouché O, Slimano F, Bourgeois V, Lebrun-Ly V, Thuillier F, Mazard T, Tavan D, Benmammar K, Monange B, Ramdani M, Péré-Vergé D, Huet-Penz F, Bedjaoui A, Genty F, Leyronnas C, Busserolles J, Trevis S, Pinon V, Pezet D, Balayssac D Long-Term Prevalence of Sensory Chemotherapy-Induced Peripheral Neuropathy for 5 Years after Adjuvant FOLFOX Chemotherapy to Treat Colorectal Cancer: A Multicenter Cross-Sectional Study. J Clin Med. 2020;9(8). doi:10.3390/jcm9082400
Bibeau F, Léger A, Bazille C, Selves J Les cancers colorectaux héréditaires vus par le pathologiste. Annales de Pathologie. 2020;40(2):105-113. doi:10.1016/j.annpat.2020.02.017
Zulfiqar M, Koen J, Nougaret S, Bolan C, VanBuren W, McGettigan M, Menias C Krukenberg Tumors: Update on Imaging and Clinical Features. AJR Am J Roentgenol. Jul 13, 2020. doi:10.2214/AJR.19.22184
Beer L, Sahin H, Bateman N, Blazic I, Vargas H, Veeraraghavan H, Kirby J, Fevrier-Sullivan B, Freymann J, Jaffe C, Brenton J, Nougaret S, Darcy K, Maxwell G, Conrads T, Huang E, Sala E Integration of proteomics with CT-based qualitative and radiomic features in high-grade serous ovarian cancer patients: an exploratory analysis. Eur Radiol. 2020-4-6. doi:10.1007/s00330-020-06755-3
Institut de Recherche en Cancérologie de
